Cracking the code: Understanding molecular signatures in ovarian cancer subgroups undergoing primary treatment

被引：0
|
作者：
Asare, Amma [1 ]
Fleming, Nicole [1 ]
Bateman, Nicholas [2 ]
Westin, Shannon [1 ]
Jazaeri, Amir [1 ]
Yao, Jun [1 ]
Hajek, Richard [1 ]
Celestino, Joseph [1 ]
Fellman, Bryan [1 ]
Rangel, Kelly [1 ]
Sey, Esther [1 ]
Cronin, Sean [2 ]
Phippen, Neil [3 ]
Lu, Karen [1 ]
Conrads, Thomas [2 ]
Maxwell, George [2 ]
Lee, Sanghoon [1 ]
Sood, Anil [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Inova Fairfax, Annandale, VA USA
[3] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1270
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [41] CONTEMPORARY TREATMENT OF PRIMARY ADVANCED EPITHELIAL OVARIAN CANCER
    Schneuber, Susanne E.
    Scholz, Heinz S.
    Bjelic-Radisic, Vesna
    Winter, Raimund
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3480 - 3480
  • [42] Primary chemotherapy patterns for ovarian cancer treatment in Japan
    Shirai, Takako
    Imanaka, Yuichi
    Sekimoto, Miho
    Ishizaki, Tatsuro
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (05) : 926 - 934
  • [43] Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency
    Huhtaniemi, Ilpo
    Hovatta, Outi
    La Marca, Antonio
    Livera, Gabriel
    Monniaux, Danielle
    Persani, Luca
    Heddar, Abdelkader
    Jarzabek, Katarzyna
    Laisk-Podar, Triin
    Salumets, Andres
    Tapanainen, Juha S.
    Veitia, Reiner A.
    Visser, Jenny A.
    Wieacker, Peter
    Wolczynski, Slawomir
    Misrahi, Micheline
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (06): : 400 - 419
  • [44] Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
    Hao, Desiree
    Sarfaraz, M. Omair
    Farshidfar, Farshad
    Bebb, D. Gwyn
    Lee, Camelia Y.
    Card, Cynthia M.
    David, Marilyn
    Weljie, Aalim M.
    METABOLOMICS, 2016, 12 (03) : 1 - 9
  • [45] Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
    Desirée Hao
    M. Omair Sarfaraz
    Farshad Farshidfar
    D. Gwyn Bebb
    Camelia Y. Lee
    Cynthia M. Card
    Marilyn David
    Aalim M. Weljie
    Metabolomics, 2016, 12
  • [46] Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer
    Geisler, JP
    Schraith, DF
    Manahan, KJ
    Sorosky, JI
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 705 - 707
  • [47] Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016
    Mukand, Nita H.
    Zolekar, Ashwini
    Ko, Naomi Y.
    Calip, Gregory S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (11) : 2220 - 2229
  • [48] Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer
    Winham, Stacey J.
    Larson, Nicholas B.
    Armasu, Sebastian M.
    Fogartyl, Zachary C.
    Larson, Melissa C.
    McCauley, Brian M.
    Wang, Chen
    Lawrenson, Kate
    Gayther, Simon
    Cunningham, Julie M.
    Fridley, Brooke L.
    Goode, Ellen L.
    HUMAN MOLECULAR GENETICS, 2019, 28 (08) : 1331 - 1342
  • [49] The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer
    Schwede, Matthew
    Waldron, Levi
    Mok, Samuel C.
    Wei, Wei
    Basunia, Azfar
    Merritt, Melissa A.
    Mitsiades, Constantine S.
    Parmigiani, Giovanni
    Harrington, David P.
    Quackenbush, John
    Birrer, Michael J.
    Culhane, Aedin C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (02) : 509 - 519
  • [50] Holistic integrated care in ovarian cancer (HICO): Improving quality of life for older patients undergoing ovarian cancer treatment
    Stettler, I.
    Toolan, M.
    Kolade, O.
    Davies, L.
    Newton, C.
    Dumas, L.
    Frost, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 8 - 8
12345